Neuropathic pain: Treatment guidelines and updates

Current Opinion in Anaesthesiology

Volumn 26, Issue 5, 2013, Pages 580-587

  Hurley, Robert W ^a   Adams, Meredith C B ^a   Benzon, Honorio T ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemotherapy; Diabetes; HIV; Neuralgia; Neuropathy; Pain; Postherpetic; Radiculopathy

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; CAPSAICIN; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CLONIDINE; DIPHENHYDRAMINE; DULOXETINE; ETANERCEPT; GABAPENTIN; KETAMINE; LAMOTRIGINE; LIDOCAINE; METHADONE; MILNACIPRAN; MORPHINE; NABILONE; NORTRIPTYLINE; OPIATE DERIVATIVE; OXALIPLATIN; OXCARBAZEPINE; PLACEBO; PREGABALIN; SOFINICLINE; TOPIRAMATE; TRAMADOL; VARICELLA ZOSTER VACCINE; VENLAFAXINE;

ARTHRALGIA; CANCER PAIN; CHRONIC PAIN; CHRONIC POSTSTROKE PAIN; COST EFFECTIVENESS ANALYSIS; CREAM; DIABETIC NEUROPATHY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG SAFETY; GEL; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPNOSIS; LOW DRUG DOSE; MEDICAID; MEDICARE; META ANALYSIS (TOPIC); NEUROPATHIC PAIN; NEUROTOXICITY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSED RADIOFREQUENCY TREATMENT; RADICULAR PAIN; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; TREATMENT DURATION; VACCINATION; VARICELLA ZOSTER VIRUS; DIABETIC NEUROPATHIES; NEURALGIA; NEURALGIA, POSTHERPETIC; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES;

DIABETIC NEUROPATHIES; HIV INFECTIONS; HUMANS; NEURALGIA; NEURALGIA, POSTHERPETIC; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84888291606     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328363b4bf     Document Type: Review

References (67)

1. IASP, Taxonomy Working Group. Classification of chronic pain. In: Descriptions of chronic pain syndromes and definitions of pain terms [WebPage]. 2nd ed. IASP, Taxonomy Working Group; 2011 .; Available from: http:// www.iasp-pain.org/Content/NavigationMenu/Publications/FreeBooks/ Classification-of-Chronic-Pain/default.htm [23 April 2013].
2. Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain 2011; 152:2204-2205.
3. Dworkin RH, Oconnor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132:237-251.
4. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007; 12:13-21.
5. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:1113-1188.
6. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 (Suppl 1):S1-S26.
7. Young L. Postherpetic neuralgia: a review of advances in treatment and prevention. J Drugs Dermatol 2006; 5:938-941.
8. Gabutti G, Serenelli C, Sarno O, et al. Epidemiologic features of patients affected by herpes zoster: database analysis of the Ferrara University Dermatology Unit, Italy. Med Mal Infect 2010; 40:268-272.
9. Langan SM, Smeeth L, Margolis DJ, et al. Herpes zoster vaccine effectiveness against incident herpes zoster and postherpetic neuralgia in an older US population: a cohort study. PLoS Med 2013; 10:e1001420.
10. Zhang L, Rainka M, Freeman R, et al. A randomized, double-blind, placebocontrolled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748). J Pain 2013; 14:590-603.
11. Wallace MS, Irving G, Cowles VE. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Investig 2010; 30:765-776.
12. Ke M, Yinghui F, Yi J, et al. Efficacy of pulsed radiofrequency in the treatment of thoracic postherpetic neuralgia from the angulus costae: a randomized, double-blinded, controlled trial. Pain Physician 2013; 16:15-25.
13. Rathur HM, Boulton AJ. Recent advances in the diagnosis and management of diabetic neuropathy. J Bone Joint Surg Br 2005; 87:1605-1610.
14. Paisley AN, Abbott CA, van Schie CH, et al. A comparison of the neuropen against standard quantitative sensory: threshold measures for assessing peripheral nerve function. Diabet Med 2002; 19:400-405.
15. Williams KA, Hurley RW, Lin E, et al. Neuropathic pain. In: Benzon HT, Rathmell JP, Wu CL, et al., editors. Benzon, Editors Raj's practical management of pain. Philadelphia: Elsevier; 2008. pp. 427-444.
16. Boyle J, Eriksson ME, Gribble L, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 2012; 35:2451-2458.
17. Sandercock D, Cramer M, Biton V, et al. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Res Clin Pract 2012; 97:438-445.
18. Rauck R, Makumi CW, Schwartz S, et al. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract 2012. [Epub ahead of print] doi: 10.1111/papr.12014.
19. Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract 2012. [Epub ahead of print] doi: 10.1111/papr.12013.
20. Martini C, Yassen A, Olofsen E, et al. Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza) in diabetic neuropathic pain patients: detection of distinct response groups. J Pain Res 2012; 5:51-59.
21. Toth C, Mawani S, Brady S, et al. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain 2012; 153:2073-2082.
22. Campbell CM, Kipnes MS, Stouch BC, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153:1815-1823.
23. Pluijms WA, Slangen R, Bakkers M, et al. Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: a pilot study. Br J Anaesth 2012; 109:623-629.
24. Bhagra A, Rao RD. Chemotherapy-induced neuropathy. Curr Oncol Rep 2007; 9:290-299.
25. Piano V, Verhagen S, Schalkwijk A, et al. Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in National Clinical Practice Guidelines From European Countries. Pain Pract 2013. [Epub ahead of print] doi: 10.1111/papr.12036.
26. Rayment C, Hjermstad MJ, Aass N, et al. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study. Palliat Med 2012. [Epub ahead of print]
27. Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309:1359-1367.
28. Durand JP, Deplanque G, Montheil V, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012; 23:200-205.
29. Hardy J, Quinn S, Fazekas B, et al. Randomized, double-blind, placebocontrolled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol 2012; 30:3611-3617.
30. Centers for Disease Control and Prevention (CDC). The Global HIV/AIDS pandemic. MMWR Morb Mortal Wkly Rep 2006; 55:841-844.
31. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 2001; 6:8-13.
32. Childs EA, Lyles RH, SelnesOA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999; 52:607-613.
33. Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. JNeurol 2004;251:1260-1266.
34. Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010; 74:413-420.
35. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003; 60:1508-1514.
36. Estanislao L, Carter K, McArthur J, et al. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 2004; 37:1584-1586.
37. Simpson DM, Brown S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008; 70:2305-2313.
38. Brown S, Simpson DM, Moyle G, et al. NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther 2013; 10:5.
39. Derry S, Sven-Rice A, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2013; (2):CD007393.
40. Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; (12):CD008242.
41. Dorfman D, George MC, Schnur J, et al. Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med 2013. [Epub ahead of print]
42. Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine (Phila Pa 1976) 2008; 33:2464-2472.
43. Younes M, Bejia I, Aguir Z, et al. Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia. JointBone Spine2006; 73:538-542.
44. Weber H, Holme I, Amlie E. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine (Phila Pa 1976) 1993; 18:1433-1438.
45. Khoromi S, Cui L, Nackers L, et al. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007; 130:66-75.
46. Khoromi S, Patsalides A, Parada S, et al. Topiramate in chronic lumbar radicular pain. J Pain 2005; 6:829-836.
47. Baron R, Freynhagen R, Tolle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain 2010; 150:420-427.
48. Olsen MB, Jacobsen LM, Schistad EI, et al. Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction. J Neurosci 2012; 32:9831-9834.
49. Pinto RZ, Maher CG, Ferreira ML, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med 2012; 157:865-877.
50. Fujii H, Kosogabe Y, Kajiki H. Long-term effects of pulsed radiofrequency on the dorsal root ganglion and segmental nerve roots for lumbosacral radicular pain: a prospective controlled randomized trial with nerve root block. Masui 2012; 61:790-793.
51. Cohen SP, White RL, Kurihara C, et al. Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial. Ann Intern Med 2012; 156:551-559.
52. Cohen SP, Bicket MC, Jamison D, et al. Epidural steroids: a comprehensive, evidence-based review. Reg Anesth Pain Med 2013; 38:175-200.
53. de Leon-Casasola OA. Opioids for chronic pain: new evidence, new strategies, safe prescribing. Am J Med 2013; 126:S3-S11.
54. Haroutiunian S, McNicol ED, Lipman AG. Methadone for chronic noncancer pain in adults. Cochrane Database Syst Rev 2012; (11): CD008025.
55. Corrigan R, Derry S, Wiffen PJ, et al. Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; (5): CD009486.
56. Zhou M, Chen N, He L, et al. Oxcarbazepine for neuropathic pain. Cochrane Database Syst Rev 2013; (3):CD007963.
57. Derry S, Gill D, Phillips T, et al. Milnacipran for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; (3): CD008244.
58. Maihofner C, Heskamp ML. Prospective, noninterventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain. First results of the QUEPP study. Curr Med ResOpin 2013; 29:673-683.
59. Kalliomaki J, Attal N, Jonzon B, et al. A randomized, double-blind, placebocontrolled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain 2013; 154:761-767.
60. Yuen E, Gueorguieva I, Bueno-Burgos L, et al. Population pharmacokinetic/ pharmacodynamic models for duloxetine in the treatment of diabetic peripheral neuropathic pain. Eur J Pain 2013; 17:382-393.
61. Chaparro LE, Wiffen PJ, Moore RA, et al. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012; CD008943.
62. Soni A, Batra R, Gwilym S, et al. Neuropathic features of joint pain: a community-based study. Arthritis Rheum 2013. [Epub ahead of print]
63. O'Donnell MJ, Diener HC, Sacco RL, et al. Chronic pain syndromes after ischemic stroke: PRoFESS trial. Stroke 2013; 44:1238-1243.
64. Jongen, Hans, N, B., et al. Neuropathic pain and pharmacological treatment. Pain Pract 2013 [Epub ahead of print]. doi: 10.1111/papr. 12085.
65. Atalay H, Solak Y, Biyik Z, et al. Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and healthrelated quality of life in haemodialysis patients. Clin Drug Investig 2013; 33:401-408.
66. Mann R, Schaefer C, Sadosky A, et al. Burden of spinal cord injuryrelated neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord 2013. [Epub ahead of print]
67. Cardenas DD, Nieshoff EC, Suda K, et al. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology 2013; 80:533-539.